Computed Tomography

SEP 4, 2026 · PHASE 3 TRIAL

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

ClinicalTrials.gov

This is an actively recruiting Phase 3 trial with no results posted; the registry record describes planned design and enrollment only, with no outcome data available for assessment.

SEP 4, 2026 · PHASE 2 TRIAL

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov

This is a Phase 2 trial registration with no results posted; it describes a planned interventional study testing TRC102 added to chemoradiotherapy in stage III NSCLC, designed to assess feasibility and signal before larger trials.

AUG 20, 2026 · PHASE 2 TRIAL

Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

ClinicalTrials.gov

This is a Phase 2 trial still recruiting with no results posted; it represents early-phase investigation of lutetium Lu 177 dotatate versus everolimus in bronchial neuroendocrine tumors.

AUG 19, 2026 · INTERVENTIONAL STUDY

Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study

ClinicalTrials.gov

This is a recruiting feasibility study with no posted results; it describes planned enrollment and outcome measures only, precluding any assessment of efficacy or clinical impact.

AUG 19, 2026 · PHASE 3 TRIAL

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

ClinicalTrials.gov

This is a Phase 3 trial registration with no posted results; the study is actively recruiting and outcome data are not yet available for analysis.

AUG 14, 2026 · PHASE 3 TRIAL

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

ClinicalTrials.gov

This is a registered but actively recruiting Phase 3 trial with no results posted; the design is sound but evidence cannot yet be evaluated.

AUG 12, 2026 · PHASE 2 TRIAL

Osimertinib With or Without Bevacizumab in Treating Patients With EGFR Positive Non-small Cell Lung Cancer and Brain Metastases

ClinicalTrials.gov

This is a Phase 2 trial registry record with only 5 enrolled participants and no results posted; it represents early-phase work that requires confirmation.

AUG 12, 2026 · PHASE 1 TRIAL

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

ClinicalTrials.gov

This is a Phase 1 safety and feasibility study of a novel PET imaging agent in a small planned cohort with no results yet reported in the registry record.